about
The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from Limited Cutaneous Systemic Sclerosis patients.Blockade of PDGF Receptors by Crenolanib Has Therapeutic Effect in Patient Fibroblasts and in Preclinical Models of Systemic Sclerosis.Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82.A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin.Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trialSerum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosisPerivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human Dermis
P50
Q36439989-A2E5BEAA-14D9-4BEC-BFDC-720154FC0E7FQ38824987-1123F8A2-F143-4B74-8485-D326C594FCC5Q47954120-EF52EAC4-3AD5-4DB0-9827-4C53ACF9BDFBQ51494982-EAB78F12-CB52-4E90-897E-53D0FF67826CQ57141751-B70919AA-0C0E-40E5-8F0C-34951F75C8ABQ58773943-CB6C16C3-389C-4118-B220-215FB92B855FQ60920917-F590E500-FDC7-4A32-B7C8-F4068F525957
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Julio C Mantero
@ast
Julio C Mantero
@de
Julio C Mantero
@en
Julio C Mantero
@es
Julio C Mantero
@fr
Julio C Mantero
@it
Julio C Mantero
@nl
type
label
Julio C Mantero
@ast
Julio C Mantero
@de
Julio C Mantero
@en
Julio C Mantero
@es
Julio C Mantero
@fr
Julio C Mantero
@it
Julio C Mantero
@nl
prefLabel
Julio C Mantero
@ast
Julio C Mantero
@de
Julio C Mantero
@en
Julio C Mantero
@es
Julio C Mantero
@fr
Julio C Mantero
@it
Julio C Mantero
@nl
P106
P21
P31
P496
0000-0003-4694-9708